PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 1, 1986Circulation Research103 citations

Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy.

View Full Paper
PGP. K. GangulyKDKen S. DhallaIII. R. Innes

Structured PICO

Does chronic diabetes alter cardiac norepinephrine turnover and metabolism in a rat model of diabetic cardiomyopathy?

P
Population
Rats 8 weeks after the induction of chronic diabetes by an intravenous injection of streptozotocin (65 mg/kg)
I
Intervention
Chronic diabetes (induced by streptozotocin) with subsequent interventions including 28-day insulin therapy, cold exposure for 6 hours, or ganglionic blockade with pentolinium
C
Comparator
Control rats
O
Outcome
Cardiac norepinephrine concentration, turnover, and uptakesurrogate

Chronic diabetes in rats is associated with increased sympathetic activity and altered cardiac norepinephrine metabolism, which can be reversed with insulin therapy.

Abstract

Cardiac norepinephrine turnover and metabolism were examined in rats 8 weeks after the induction of chronic diabetes by an intravenous injection of streptozotocin (65 mg/kg). Cardiac norepinephrine concentration, norepinephrine turnover, and norepinephrine uptake were markedly increased in chronic diabetes in comparison with control values; these changes were reversible by 28-day insulin therapy. When the animals were exposed to cold for 6 hours, norepinephrine turnover rate constant increased in control and decreased in diabetic animals; cold exposure also increased norepinephrine concentration in diabetic hearts. Both cardiac norepinephrine concentration and turnover rate in diabetic rats were restored toward control values by ganglionic blockade with pentolinium. The conversion of 3Htyrosine to 3Hcatecholamine was enhanced and tyrosine hydroxylase as well as dopa decarboxylase activities were increased in diabetic hearts. The higher concentrations of 3Hnormetanephrine and deaminated catechols indicated a faster metabolic rate of norepinephrine metabolism in hearts from diabetic rats; both monoamine oxidase and catechol-O-methyltransferase activities were also increased. The increased activities of the enzymes for the synthesis and metabolism of norepinephrine were not evident on treating the diabetic animals with insulin. These data not only support the view that chronic diabetes in rats is associated with increased sympathetic activity but also indicate that the cardiac norepinephrine concentration in diabetic rats may be maintained at a higher than normal level by an increased synthesis and uptake of norepinephrine in the adrenergic nerve terminals.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ganguly et al. (1986) studied this question.

synapsesocial.com/papers/6a958a0bcd4f73a2bd828235https://doi.org/10.1161/01.res.59.6.684
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Plasma Norepinephrine and Epinephrine in Untreated Diabetics, During Fasting and After Insulin Administration1974 · 292 citations
  2. 2Alterations in Ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes.1983 · 130 citations
  3. 3Plasma Catecholamines in Long-Term Diabetics with and without Neuropathy and in Hypophysectomized Subjects1972 · 175 citations
  4. 4Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure1965 · 574 citations
  5. 5Plasma catecholamines in clinical studies of cardiovascular diseases.1984 · 28 citations